Speakers 2022

Speakers 2022

Nathalie LABARRIERE

Directrice Recherche INSERM


OPTIMISING T CELLS FOR ADOPTIVE CELL TRANSFER APPROCHES IN MELANOMA (title to be confirmed)

TUESDAY, SEPTEMBER 20TH

Nathalie Labarriere is Inserm Research Director, in charge of the team 3 « Anti-tumor immunosurveillance and immunotherapy» and deputy director of the INCIT Unit (Immunology and new concepts in Immunotherapy).   She started working in 1990 on tumor immunology in Nantes and developped research programs translational immunology, in close collaboration with clinical teams, particularly in the field of melanoma immunotherapy, with Pr Brigitte Dreno.   Since 2010, Dr. Labarriere has been leading the team whose work has led to several clinical trials on adoptive T cell transfer in melanoma patients. Dr. Labarriere is the author of 88 publications and 6 patents. She is also responsible for the cytometry platform of the SFR Bonamy and participates in several scientific boards and committees in the field of immunotherapy. She was director of the LabEx IGO (Immunograft-Oncology) from 2013 to 2016, member of the CN1 of the ARC (2017-2021), and currently member of the CSS5 Inserm (Immunology).

Find also